Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Truneh

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Nature|November 29, 1990
Crystal structure of an HIV-binding recombinant fragment of human CD4S E Ryu, P D Kwong, A Truneh, et al.
Methods in Enzymology|August 17, 2000
Measurement of protein interaction bioenergetics: application to structural variants of anti-sCD4 antibodyM L Doyle, M Brigham-Burke, M N Blackburn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokinesJ A Harrop, M Reddy, K Dede, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptorY Morel, J M Schiano de Colella, J Harrop, et al.
The Journal of Biological Chemistry|April 20, 2000
Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptorA Truneh, S Sharma, C Silverman, et al.
Human & Experimental Toxicology|August 3, 2000
Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studiesP J Bugelski, D J Herzyk, S Rehm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4M P Reddy, C A Kinney, M A Chaikin, et al.
The Journal of Biological Chemistry|October 9, 1998
Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growthJ A Harrop, P C McDonnell, M Brigham-Burke, et al.
The Journal of Biological Chemistry|May 30, 1997
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activationB S Kwon, K B Tan, J Ni, et al.
Clinical Immunology (Orlando, Fla.)|February 13, 2001
Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzeesR Newman, K Hariharan, M Reff, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Nature|November 29, 1990
Crystal structure of an HIV-binding recombinant fragment of human CD4S E Ryu, P D Kwong, A Truneh, et al.
Methods in Enzymology|August 17, 2000
Measurement of protein interaction bioenergetics: application to structural variants of anti-sCD4 antibodyM L Doyle, M Brigham-Burke, M N Blackburn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokinesJ A Harrop, M Reddy, K Dede, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptorY Morel, J M Schiano de Colella, J Harrop, et al.
The Journal of Biological Chemistry|April 20, 2000
Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptorA Truneh, S Sharma, C Silverman, et al.
Human & Experimental Toxicology|August 3, 2000
Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studiesP J Bugelski, D J Herzyk, S Rehm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4M P Reddy, C A Kinney, M A Chaikin, et al.
The Journal of Biological Chemistry|October 9, 1998
Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growthJ A Harrop, P C McDonnell, M Brigham-Burke, et al.
The Journal of Biological Chemistry|May 30, 1997
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activationB S Kwon, K B Tan, J Ni, et al.
Clinical Immunology (Orlando, Fla.)|February 13, 2001
Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzeesR Newman, K Hariharan, M Reff, et al.
Pageof 7